Approval · Notice of Compliance 31258 · 2023
APO-BACLOFEN: Notice of Compliance 31258
Issued July 20, 2023
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 31258
- Date
- July 20, 2023
- Company
- Apotex Inc.Toronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Update to labels to align with Plain Language Labelling Regulations
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| APO-BACLOFEN | Not yet assigned | — |